Latest Headlines

  1. Coating Place Secures Growth Capital Investment By 1315 Capital 1/16/2026

    Coating Place, a leading U.S.-based contract development and manufacturing organization (CDMO), has secured a strategic, growth investment from 1315 Capital, a Philadelphia-based healthcare-focused private equity firm.

  2. INTERPHEX Opens Registration For 2026 With Expanded Show Floor, Education And Debut Of New Contract & Outsourcing Hub 1/14/2026

    INTERPHEX, the premier pharmaceutical and biotechnology event returns to NYC, taking place April 21 – 23 at the Javits Center. Representing the full scope of the pharmaceutical value chain, INTERPHEX continues to be the event to discover breakthrough solutions that enhance manufacturing, development, regulatory compliance and supply chain efficiency to support the evolving industry.

  3. AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services 1/14/2026

    The acquisition of the Tempe, Arizona facility will expand U.S.-based drug delivery device capacity and support the company’s $10 billion manufacturing investment.

  4. Johnson & Johnson Announces Plans For New Manufacturing Facilities In North Carolina And Pennsylvania 1/13/2026

    Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare’s leading, most comprehensive innovation powerhouse, today announced a voluntary agreement with the Trump Administration to improve access to medicines and lower costs for millions of American patients. The joint agreement meets the requests laid out by President Trump to the industry and provides the Company’s pharmaceutical products an exemption from tariffs.

  5. Sharp Sterile Manufacturing Increases Capacity With $28 Million Investment Featuring New IMA Isolated Vial Filling Line 1/8/2026

    Sharp Sterile Manufacturing has today announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will strengthen opportunities for highly skilled engineering and pharmaceutical manufacturing roles within the local life sciences community and represents a major milestone in Sharp Sterile’s development.

  6. CDMO GBI Biomanufacturing Announces New President 1/6/2026

    GBI Biomanufacturing, a U.S.-based biopharmaceutical CDMO providing integrated development and cGMP manufacturing services for complex biologics, today announced that Jesse McCool, Ph.D. has been appointed President.

  7. Symbiosis Initiates Commercial Drug Manufacturing At New FDA-Inspected Production Facility 1/6/2026

    (Symbiosis), a leading sterile fill finish contract manufacturing organisation (CMO), has manufactured their first 10,000 vial batch at the company’s new facility in Stirling, UK.

  8. Samsung Biologics Expands U.S. Manufacturing Capabilities With Strategic Acquisition Of Human Genome Sciences From GSK 12/22/2025

    This strategic move secures Samsung Biologics’ first U.S.-based manufacturing site, a significant expansion of the company’s global footprint and its long-term commitment to the U.S. market.

  9. Techceuticals Releases 2026 Schedule For In-Person Solid Dosage Manufacturing Training 12/19/2025

    Techceuticals has announced its 2026 training schedule for solid dosage manufacturing, featuring a full lineup of two-day, hands-on courses covering tablet making, encapsulation, granulation, film coating, and end-to-end solid dosage processes.

  10. Sanofi Toronto Equipment Assets Auction Announced For January 2026 12/19/2025

    Federal Equipment Company, a trusted global provider of surplus pharmaceutical and chemical processing equipment, announced it will conduct a two-day online auction on behalf of Sanofi featuring quality process and laboratory equipment surplus to the company’s ongoing operational needs.